PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit talks about her experiences and highlights from the 2026 PanCAN ...

Imagine watching the sunrise from Uhuru Peak — 19,341 feet above sea level — knowing every step you took helped fuel progress for patients with pancreatic cancer and families. This is more than a trek ...

PanCAN PurpleStride, the ultimate walk to end pancreatic cancer, will take place the weekend of April 24, 2027. Find an event ...

Pittsburgh Event Day Volunteer Chair Kecia Scott spoke with PanCAN’s Paula Mukherjee about her journey as a caregiver and ...

Nadine: My father, Eddie, was diagnosed with pancreatic cancer in 2003. He was only 46. He passed away the following year. Paula: How did your father get diagnosed? Nadine: He was experiencing a lot ...

In 2026, in partnership with our generous donors and supporters, 12 research grants have been awarded through two programs. Grantees were selected through a peer-review process. PanCAN has awarded ...

The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few ...

The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today following the full data from Revolution ...

I can’t think of a more exciting and hopeful time for pancreatic cancer than now. We are finally beginning to reap the benefits of decades of research into this challenging cancer. Because KRAS ...

One of the most common conditions associated with pancreatic cancer may also be one of the least understood: Cancer cachexia. Sometimes known as wasting syndrome, cancer cachexia is the loss of 5% or ...

LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...